Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Angiosarcoma
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Causes == Angiosarcoma develops when damage to the [[DNA]] of [[Endothelium|endothelial cells]] causes them to [[Cell proliferation|divide uncontrollably]] and prevents [[Programmed cell death|programmed death]]. This allows them to grow into a [[Neoplasm|mass]] invading other parts of the body and consuming its resources. If part of the mass breaks off and enters the [[Circulatory system|circulatory]] or [[lymphatic system]] (which is very common due to angiosarcomas arising from the [[Endothelium|lining]] of said systems) it allows them to lodge elsewhere in the body. This process is called [[metastasis]] and is a negative prognostic factor.<ref>{{Cite web|date=2007-09-17|title=What Is Cancer? - National Cancer Institute|url=https://www.cancer.gov/about-cancer/understanding/what-is-cancer|access-date=2021-08-09|website=www.cancer.gov|language=en}}</ref> The underlying causes of DNA damage is not understood but several risk factors are widely accepted.{{citation needed|date=October 2021}} Accepted risk factors include [[lymphedema]], [[radiation therapy]], [[neurofibromatosis]], [[Maffucci syndrome]], [[Klippel–Trénaunay syndrome|Klippel-Trenaunay syndrome]]<ref name="Angiosarcoma" /> and chemicals such as [[arsenic]], [[thorotrast]] and [[vinyl chloride]].<ref name="cancer.gov" /> A 2020 study analyzing the [[genome]] of cutaneous angiosarcomas suggests that [[Ultraviolet|ultraviolet radiation]] may be a [[Carcinogen|causative agent]] of angiosarcomas.<ref name="project">{{Cite journal|last1=Painter|first1=Corrie A.|last2=Jain|first2=Esha|last3=Tomson|first3=Brett N.|last4=Dunphy|first4=Michael|last5=Stoddard|first5=Rachel E.|last6=Thomas|first6=Beena S.|last7=Damon|first7=Alyssa L.|last8=Shah|first8=Shahrayz|last9=Kim|first9=Dewey|last10=Gómez Tejeda Zañudo|first10=Jorge|last11=Hornick|first11=Jason L.|date=February 2020|title=The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research|url=https://pubmed.ncbi.nlm.nih.gov/32042194/|journal=Nature Medicine|volume=26|issue=2|pages=181–187|doi=10.1038/s41591-019-0749-z|issn=1546-170X|pmid=32042194|s2cid=211074464}}</ref> [[Immunosuppression]] may play a role in the [[pathogenesis]] of angiosarcoma. There have been reports of angiosarcoma in [[Immunosuppression|immunosuppressed]] individuals following [[kidney transplantation]]. The association between lymphedema and angiosarcoma may be due to localized [[immunodeficiency]], however this [[hypothesis]] has not been confirmed. Some studies suggest a link between [[HIV/AIDS|AIDS]] and angiosarcoma though this may be due to [[Medical error|misdiagnosed]] [[Kaposi's sarcoma]].<ref name="Angiosarcoma" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)